Supernus Pharmaceuticals Inc (SUPN)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	605,106	619,414	641,163	674,751	673,056	651,277	618,187	585,808	560,079	545,016	551,524	536,576	506,717	465,383	418,476	402,257	392,755	408,243	409,099	403,942
Total assets	US$ in thousands	1	1,285,160	1,293,100	1,791,810	1,702,510	1,693,130	1,694,970	1,639,520	1,689,150	1,555,040	1,573,060	1,507,440	1,504,100	1,510,020	1,491,020	1,189,870	1,160,280	1,106,910	1,063,680	1,025,450
Total asset turnover		605,106.00	0.48	0.50	0.38	0.40	0.38	0.36	0.36	0.33	0.35	0.35	0.36	0.34	0.31	0.28	0.34	0.34	0.37	0.38	0.39

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $605,106K ÷ $1K
= 605,106.00

The total asset turnover ratio of Supernus Pharmaceuticals Inc has shown some fluctuations over the past eight quarters, ranging from 0.37 to 0.49. This ratio indicates the company's ability to generate sales revenue relative to its total assets. A higher ratio generally suggests that the company is efficiently utilizing its assets to generate sales.

The consistency in the range of 0.37 to 0.49 over the quarters indicates that Supernus Pharmaceuticals Inc has been able to maintain a relatively stable level of asset efficiency. However, the ratio of 0.49 in Q2 2023 represents a peak in asset turnover for the period analyzed, implying that the company was able to generate more sales revenue per dollar of assets during that quarter.

Overall, the total asset turnover ratio for Supernus Pharmaceuticals Inc shows a moderate level of efficiency in utilizing its assets to generate sales revenue, with some variation observed over the quarters. It would be advisable for the company to continue monitoring and seeking ways to improve this ratio to enhance operational efficiency and profitability.